# MT Combined With XKSA for Depressive Symptoms During COVID-19

> **NCT05631145** · NA · COMPLETED · sponsor: **Renrong Wu** · enrollment: 59 (actual)

## Conditions studied

- Depression, Anxiety

## Interventions

- **OTHER:** MT Combined With XKSA
- **OTHER:** MT

## Key facts

- **NCT ID:** NCT05631145
- **Lead sponsor:** Renrong Wu
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-03
- **Primary completion:** 2020-10-01
- **Final completion:** 2020-10-15
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2022-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05631145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05631145, "MT Combined With XKSA for Depressive Symptoms During COVID-19". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05631145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*